These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Troponin I and echocardiography in patients with systemic sclerosis and matched population controls. Nordin A, Svenungsson E, Björnådal L, Elvin K, Larsson A, Jensen-Urstad K. Scand J Rheumatol; 2017 May; 46(3):226-235. PubMed ID: 27601074 [Abstract] [Full Text] [Related]
24. Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED-J Study. Wada H, Shinozaki T, Suzuki M, Sakagami S, Ajiro Y, Funada J, Matsuda M, Shimizu M, Takenaka T, Morita Y, Yonezawa K, Matsubara H, Ono Y, Nakamura T, Fujimoto K, Ninomiya A, Kato T, Unoki T, Takagi D, Wada K, Wada M, Iguchi M, Yamakage H, Kusakabe T, Yasoda A, Shimatsu A, Kotani K, Satoh-Asahara N, Abe M, Akao M, Hasegawa K, EXCEED‐J Study Investigators. J Am Heart Assoc; 2022 Feb; 11(3):e023464. PubMed ID: 35048713 [Abstract] [Full Text] [Related]
25. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Binder L, Pieske B, Olschewski M, Geibel A, Klostermann B, Reiner C, Konstantinides S. Circulation; 2005 Sep 13; 112(11):1573-9. PubMed ID: 16144990 [Abstract] [Full Text] [Related]
26. Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia. Puelacher C, Wagener M, Honegger U, Assadian M, Schaerli N, Mueller D, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Sabti Z, Sazgary L, Badertscher P, du Fay de Lavallaz J, Marbot S, Kaiser C, Wild D, Zellweger MJ, Reichlin T, Mueller C. Clin Biochem; 2018 Feb 13; 52():33-40. PubMed ID: 29107010 [Abstract] [Full Text] [Related]
28. High-sensitivity cardiac troponin decrease after percutaneous coronary intervention in patients with stable coronary artery disease. Hamaya R, Horie T, Yonetsu T, Sugano A, Kanaji Y, Usui E, Hoshino M, Yamaguchi M, Ohya H, Sumino Y, Hada M, Hirano H, Kanno Y, Yuki H, Hirao K, Kakuta T. Heart Vessels; 2019 Jun 13; 34(6):948-956. PubMed ID: 30600349 [Abstract] [Full Text] [Related]
31. Superiority of high sensitivity cardiac troponin I over NT-proBNP and adiponectin for 7-year mortality in stable patients receiving haemodialysis. Iwamura N, Kidoguchi S, Asahi N, Takeda I, Matsuta K, Miyagi K, Iwano M, Miyazaki R, Kimura H. Sci Rep; 2024 May 20; 14(1):11488. PubMed ID: 38769120 [Abstract] [Full Text] [Related]
32. Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome. Eggers KM, Lagerqvist B, Oldgren J, Venge P, Wallentin L, Lindahl B. Am Heart J; 2008 Sep 20; 156(3):588-94. PubMed ID: 18760145 [Abstract] [Full Text] [Related]
35. N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study. Cheng H, Fan WZ, Wang SC, Liu ZH, Zang HL, Wang LZ, Liu HJ, Shen XH, Liang SQ. J Crit Care; 2015 Jun 20; 30(3):654.e9-14. PubMed ID: 25575850 [Abstract] [Full Text] [Related]